https://www.dcatvci.org/top-industry-news/astrazeneca-s-medimmune-opens-new-cancer-r-d-lab/
AstraZeneca's MedImmune Opens New Cancer R&D Lab - DCAT Value Chain Insights
Sep 8, 2021 - MedImmune, the biologics arm of AstraZeneca, the Cancer Research UK, and its commercial arm, Cancer Research Technology, have opened a new laboratory that will...
https://www.homelandsecuritynewswire.com/medimmune-explore-buy-out-options
MedImmune to explore buy-out options | Homeland Security Newswire
to explorebuy outhomeland securitymedimmuneoptions